Recent Finacing
Recent Raise
Denali Therapeutics develops therapeutics for neurodegenerative diseases, advancing programs targeting degenogenes, intracellular trafficking, glial dysfunction, axon degeneration, and a blood-brain barrier delivery platform.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors